marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
Cytokinetics, Incorporated Financial Ratios 2011-2024 | CYTK
Annual Financial Ratios Cytokinetics, Incorporated
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.0 | -0.0 | -0.0 | -0.0 | -6.1 | -3.6 | -3.6 | 24.4 | -8.0 | -17.3 | -6.5 | -3.0 | -1.5 |
P/S |
0.9 | 0.0 | 0.0 | 0.0 | 27.6 | 12.0 | 34.0 | 3.8 | 10.4 | 5.4 | 7.1 | 15.8 | 18.4 |
EPS |
-5.5 | -4.3 | -2.8 | -2.0 | -2.1 | -1.9 | -2.6 | 0.4 | -1.0 | -0.4 | -1.2 | -2.3 | -0.7 |
EV (Enterprise Value) |
1.1 B | 1.06 B | 488 M | 339 M | 1 B | 521 M | 514 M | 410 M | 280 M | 274 M | 228 M | 112 M | 59.4 M |
EBITDA per Share |
-5.02 K | -3.54 K | -2.39 K | -1.43 K | -1.69 | -1.61 | -2.26 | 0.486 | -0.949 | -0.399 | -1.23 | -2.2 | -3.85 |
EV/EBITDA |
-2.7 | -14.4 | -8.5 | -4.3 | -3.2 | 18.8 | -6.7 | -16.3 | -5.9 | -2.6 | -1.2 | ||
PEG |
-0.0 | -0.0 | -0.0 | -0.0 | 0.74 | -0.14 | 0.0 | 0.17 | 0.06 | -0.26 | -0.15 | -0.06 | -0.24 |
P/B |
-0.0 | -0.0 | 0.0 | 0.0 | -67.7 | 14.6 | 4.1 | 4.3 | 4.4 | 2.8 | 4.0 | 1.7 | 1.5 |
P/CF |
-0.0 | -0.0 | -0.0 | 0.1 | -7.9 | -3.7 | -4.3 | 11.3 | 69.2 | -5.5 | -26.5 | -3.6 | -1.6 |
ROE % |
136.22 | 360.48 | -88.29 | -112.27 | 1112.66 | -409.84 | -116.34 | 17.44 | -54.67 | -15.91 | -61.93 | -57.60 | -99.34 |
ROA % |
-63.84 | -38.33 | -25.59 | -23.85 | -41.99 | -50.33 | -43.35 | 9.67 | -32.54 | -11.01 | -40.53 | -52.06 | -90.69 |
ROCE % |
128.44 | 300.47 | -76.40 | -82.85 | -37.48 | -47.05 | -43.22 | 13.65 | -44.75 | -13.52 | -60.01 | -57.51 | -97.08 |
Current Ratio |
0.7 | 0.9 | 1.4 | 1.3 | 9.0 | 9.4 | 8.5 | 4.8 | 3.6 | 5.5 | 3.0 | 10.8 | 11.1 |
DSO |
34.7 | 100.3 | 145.7 | 31.3 | 70.1 | 78.6 | 30.4 | 0.1 | 0.2 | 362.7 | 0.1 | 0.2 | 1.3 |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
34.7 | 100.3 | 145.7 | 31.3 | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
34.7 | 100.3 | 145.7 | 31.3 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Cytokinetics, Incorporated
| 2024-Q3 | 2024-Q2 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-1.36 | -1.31 | -1.35 | -1.34 | -1.38 | - | -1.52 | -0.23 | -1.05 | - | -0.95 | -0.86 | -0.66 | - | -0.05 | -0.68 | -0.66 | - | -0.5 | -0.56 | -0.54 | - | -0.4 | -0.51 | -0.56 | - | -0.6 | -0.6 | -0.62 | 0.18 | 0.84 | -0.29 | -0.31 | - | -0.23 | -0.27 | -0.23 | - | -0.16 | -0.23 | -0.27 | 0.22 | -0.43 | -0.58 | -0.53 | - | -0.45 | -0.76 | -0.13 | - | -0.15 | -0.23 | -0.18 |
EBITDA per Share |
- | - | - | - | -1.29 K | - | -1.11 K | -127 | -900 | - | -842 | -764 | -563 | - | 95.8 | -529 | -505 | - | -393 | -454 | -442 | - | -0.3 | -0.41 | -0.47 | - | -0.5 | -0.5 | -0.55 | - | 0.86 | -0.27 | -0.3 | - | -0.22 | -0.27 | -0.23 | - | -0.15 | -0.22 | -0.26 | - | -0.42 | -0.58 | -0.52 | - | -0.43 | -0.64 | -0.13 | - | -0.13 | -0.18 | -0.15 |
ROE % |
1090.17 | -6.59 | 1016.16 | 1877.38 | 1820.97 | 795.99 | 765.44 | -155.83 | -511.35 | -473.29 | -476.09 | -448.33 | -110.99 | -73.52 | 196.87 | 470.07 | 799.65 | 832.51 | 747.62 | 392.33 | -7.42 | -307.79 | -344.64 | -289.20 | -209.55 | -116.34 | -71.90 | -7.08 | 7.09 | 17.44 | -3.60 | -51.86 | -54.94 | -54.67 | -32.05 | -25.63 | -19.35 | -15.91 | -13.08 | -29.72 | -48.25 | -61.93 | -90.27 | -81.48 | -66.61 | -57.60 | -65.91 | -73.66 | -89.20 | -99.34 | -22.08 | -28.30 | -24.31 |
ROA % |
-54.55 | -58.13 | -61.95 | -57.70 | -51.65 | -34.12 | -43.31 | -28.83 | -39.74 | -28.26 | -28.86 | -20.26 | -16.99 | -15.62 | -25.82 | -35.43 | -38.87 | -31.42 | -41.84 | -42.06 | -44.02 | -37.80 | -51.53 | -52.08 | -48.91 | -43.35 | -25.41 | 5.18 | 8.22 | 9.67 | -2.55 | -29.83 | -32.16 | -32.54 | -18.18 | -15.00 | -12.14 | -11.01 | -9.51 | -20.15 | -31.94 | -40.53 | -63.15 | -60.97 | -54.42 | -52.06 | -59.79 | -67.00 | -81.30 | -90.69 | -20.16 | -25.83 | -22.19 |
ROCE % |
956.74 | -1.07 | 797.58 | 1448.45 | 1402.05 | 602.00 | 574.22 | -132.31 | -454.87 | -419.97 | -415.40 | -383.04 | -79.25 | -50.74 | 168.03 | 382.23 | 655.04 | 687.22 | 618.14 | 330.30 | -4.26 | -260.11 | -285.99 | -242.79 | -175.45 | -69.98 | -33.99 | 27.89 | 39.15 | 11.66 | -1.30 | -50.25 | -54.02 | -41.39 | -47.90 | -41.46 | -35.15 | -25.17 | -48.34 | -64.99 | -83.53 | -74.07 | -88.44 | -79.65 | -64.75 | -41.33 | -63.48 | -71.25 | -86.79 | -74.86 | -22.14 | -28.33 | -24.39 |
Current Ratio |
1.0 | 1.1 | 0.6 | 0.7 | 0.8 | 0.9 | 1.0 | - | 1.2 | 1.4 | 1.4 | 1.0 | 1.1 | 1.3 | 1.3 | 1.3 | 1.3 | 1.0 | 1.0 | 1.0 | 1.0 | 1.1 | 1.1 | 1.1 | 1.1 | 1.6 | 1.6 | 1.6 | 1.6 | 2.2 | 2.2 | 2.2 | 2.2 | 2.5 | 2.5 | 2.5 | 2.5 | 3.2 | 3.2 | 3.2 | 3.2 | 2.9 | 2.9 | 2.9 | 2.9 | 10.4 | 10.4 | 10.4 | 10.4 | 11.5 | 11.5 | 11.5 | 11.5 |
DSO |
- | - | 420.5 | 104.8 | 11.4 | - | 41.6 | 3.1 | 2300.1 | - | 28.1 | 115.8 | 62.2 | - | 9.7 | 112.2 | 114.3 | - | 77.8 | 66.0 | 39.9 | - | 19.1 | 32.8 | 28.9 | -5637.2 | 16.4 | 33.2 | 12.5 | 0.1 | 0.0 | 0.2 | 1.1 | 0.9 | - | - | 1.1 | 0.2 | - | - | 1.2 | 0.4 | - | - | 10.4 | 3.9 | - | - | 5.2 | 12.4 | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | 420.5 | 104.8 | 11.4 | - | 41.6 | 3.1 | 2300.1 | - | 28.1 | 115.8 | 62.2 | - | 9.7 | 112.2 | 114.3 | - | 77.8 | 66.0 | 39.9 | - | 19.1 | 32.8 | 28.9 | -5637.2 | 16.4 | 33.2 | 12.5 | 0.1 | 0.0 | 0.2 | 1.1 | 0.9 | - | - | 1.1 | 0.2 | - | - | 1.2 | 0.4 | - | - | 10.4 | 3.9 | - | - | 5.2 | 12.4 | - | - | - |
Cash Conversion Cycle |
- | - | 420.5 | 104.8 | 11.4 | - | 41.6 | 3.1 | 2300.1 | - | 28.1 | 115.8 | 62.2 | - | 9.7 | 112.2 | 114.3 | - | 77.8 | 66.0 | 39.9 | - | 19.1 | 32.8 | 28.9 | -5637.2 | 16.4 | 33.2 | 12.5 | 0.1 | 0.0 | 0.2 | 1.1 | 0.9 | - | - | 1.1 | 0.2 | - | - | 1.2 | 0.4 | - | - | 10.4 | 3.9 | - | - | 5.2 | 12.4 | - | - | - |
All numbers in USD currency